DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $70,000 | -34.6% | 241 | -25.8% | 0.01% | -30.8% |
Q4 2021 | $107,000 | +8.1% | 325 | 0.0% | 0.01% | -7.1% |
Q3 2021 | $99,000 | +13.8% | 325 | 0.0% | 0.01% | +16.7% |
Q2 2021 | $87,000 | +22.5% | 325 | +3.2% | 0.01% | +9.1% |
Q1 2021 | $71,000 | +1.4% | 315 | 0.0% | 0.01% | -8.3% |
Q4 2020 | $70,000 | +2.9% | 315 | 0.0% | 0.01% | -7.7% |
Q3 2020 | $68,000 | +21.4% | 315 | 0.0% | 0.01% | +8.3% |
Q2 2020 | $56,000 | +27.3% | 315 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $44,000 | -8.3% | 315 | 0.0% | 0.01% | +9.1% |
Q4 2019 | $48,000 | -7.7% | 315 | -12.5% | 0.01% | -15.4% |
Q3 2019 | $52,000 | +4.0% | 360 | +3.7% | 0.01% | 0.0% |
Q2 2019 | $50,000 | -40.5% | 347 | -45.4% | 0.01% | -43.5% |
Q1 2019 | $84,000 | +115.4% | 635 | +69.8% | 0.02% | +91.7% |
Q4 2018 | $39,000 | -4.9% | 374 | 0.0% | 0.01% | -7.7% |
Q3 2018 | $41,000 | +10.8% | 374 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $37,000 | 0.0% | 374 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $37,000 | +5.7% | 374 | 0.0% | 0.01% | +8.3% |
Q4 2017 | $35,000 | +9.4% | 374 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $32,000 | 0.0% | 374 | 0.0% | 0.01% | -7.7% |
Q2 2017 | $32,000 | 0.0% | 374 | 0.0% | 0.01% | -7.1% |
Q1 2017 | $32,000 | -13.5% | 374 | -21.1% | 0.01% | -26.3% |
Q4 2016 | $37,000 | 0.0% | 474 | 0.0% | 0.02% | 0.0% |
Q3 2016 | $37,000 | -2.6% | 474 | +26.7% | 0.02% | -9.5% |
Q2 2016 | $38,000 | +8.6% | 374 | 0.0% | 0.02% | +5.0% |
Q1 2016 | $35,000 | 0.0% | 374 | 0.0% | 0.02% | -4.8% |
Q4 2015 | $35,000 | +9.4% | 374 | 0.0% | 0.02% | +5.0% |
Q3 2015 | $32,000 | 0.0% | 374 | 0.0% | 0.02% | +5.3% |
Q2 2015 | $32,000 | 0.0% | 374 | 0.0% | 0.02% | 0.0% |
Q1 2015 | $32,000 | 0.0% | 374 | 0.0% | 0.02% | -13.6% |
Q4 2014 | $32,000 | +14.3% | 374 | 0.0% | 0.02% | +10.0% |
Q3 2014 | $28,000 | -3.4% | 374 | 0.0% | 0.02% | 0.0% |
Q2 2014 | $29,000 | +3.6% | 374 | 0.0% | 0.02% | 0.0% |
Q1 2014 | $28,000 | – | 374 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |